08.10.2021 • News

Huntsman Forms Korean Polyurethanes JV

Huntsman has formed a joint venture with South Korean polyols producer KPX Chemical. The jv, named KPX Huntsman Polyurethanes Automotive, will develop and produce polyurethane systems for South Korean automakers from KPX's plant in Ulsan. Operations are expected to start by the end of October.

The partnership will leverage Huntsman's ability to develop high-performance differentiated MDI-based products for car manufacturers together with KPX's 47-year experience in polyol technology and knowhow. The companies added that the it will accelerate growth in the South Korean automotive industry, which presents new opportunities for high-performance and light weight PU systems.

"It is an exciting time to be creating a new venture and we look forward to working with key players in the region to meet growing demand for autonomous vehicles and electric transport solutions that can support the country's carbon neutrality ambitions," said Kim Moon-young, president of KPX Chemical.

Author: Elaine Burridge, Freelance Journalist

Huntsman has formed a joint venture with South Korean polyols producer KPX...
Huntsman has formed a joint venture with South Korean polyols producer KPX Chemical. The jv – KPX Huntsman Polyurethanes Automotive – will produce polyurethane systems for South Korean automakers from KPX's plant in Ulsan. Operations are expected to start by the end of October. (c) Huntsman

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read